National Vision (EYE) vs RxSight (RXST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
National Vision (EYE) has outperformed RxSight (RXST) over the past year, losing 39.5% versus a loss of 42.0%. Over five years, RXST leads with a -64.6% price change compared with -73.5% for EYE. National Vision is the larger company by market cap ($1.32 billion vs $200.5 million), about 6.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EYE | RXST |
|---|---|---|
| Share price | $16.75 | $4.82 |
| Market cap | $1.32B | $200.48M |
| 1-day change | -0.45% | +0.42% |
| YTD return | -34.86% | -53.93% |
| 1-year return | -39.50% | -42.03% |
| 5-year return | -73.52% | -64.60% |
| P/E ratio (TTM) | 27.01 | — |
| Forward P/E | 13.86 | — |
| EPS (TTM) | $0.62 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $30.02 | $13.22 |
| 52-week low | $14.75 | $4.48 |
| Distance from 52-week high | -44.22% | -63.54% |
| Analyst consensus | none | none |
| Avg. price target upside | +68.29% | +57.05% |
| Average volume | 2.15M | 861.57K |
| Shares outstanding | 79.07M | 41.59M |
| Employees | 13,138 | 461 |
| Sector | Health Care | Health Care |
| Industry | Ophthalmic Goods | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- National Vision is about 6.6 times larger than RxSight by market value ($1.32B vs $200.48M).
About National Vision
EYE stock →National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company offers eyeglasses and contact lenses, and optical accessory products; and provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, Vista Optical military, and DiscountContacts.com.
Health Care · Ophthalmic Goods · 13,138 employees
About RxSight
RXST stock →RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.
Health Care · Ophthalmic Goods · 461 employees
EYE vs RXST FAQ
Which is bigger, National Vision or RxSight?
National Vision (EYE) is larger, with a market capitalization of $1.32B compared with $200.48M for RxSight (RXST).
Which stock has performed better over the past year, EYE or RXST?
EYE returned -39.50% over the past 12 months, compared with -42.03% for RXST (price return, excluding dividends). Past performance does not predict future results.
Are National Vision and RxSight in the same industry?
Yes. Both are classified in the Ophthalmic Goods industry within the Health Care sector.